There are so many grants for so many different projects, research, and ideas! So, take your time, look around, and learn all there is to know about grants and how your organization can use these resources to excel!
Check out this funding opportunity!
Have several questions and need help?
The NIA provides more than $100 million in no-strings-attached, non-dilutive funding through programs that support small businesses, including the Small Business Innovation Research and Small Business Technology Transfer programs. For small businesses and research organizations working on solutions for Alzheimer’s disease (AD) and AD-related dementias (ADRD), NIA has targeted solicitations for SBIR and STTR that allow for higher budget limits of up to $500,000 for Phase I and $2.5 million for Phase II.
This opportunity represents scientific program areas that may be of interest to applicant small businesses in the development of projects that have the potential for commercialization. Small business concerns that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, or FDA awarding components identified in this opportunity are encouraged to submit SBIR grant applications in these areas.
Objective of the SBIR and STTR Programs:
Increase private-sector commercialization of innovations derived from federally supported research and development. After an SBIR/STTR Phase II, it is expected that the small business will fully commercialize their product or technology using non-SBIR/STTR funds (either federal or non-federal).
2020 NIH SBIR Omnibus Solicitation – Clinical Trial Not Allowed
Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD)
Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer's Disease (AD/ADRD)